Uncategorized

R-Biopharm AG and Apacor Limited announce exclusive partnership in Germany for faecal parasite enrichment system Exclusive distribution of the innovative and patented Mini & Midi Parasep® [...]

The WHO recommends expanding testing for Mpox (Monkeypox) The newly circulating virus variant Mpox clade Ib is much more contagious and can cause more severe courses of disease than the variant [...]

Bordetella pertussis infections continue to rise! In contrast to the time before and during the Covid pandemic, we are currently seeing alarmingly high numbers of respiratory infections caused by [...]

Ready to embrace the future of T-cell based Tuberculosis diagnosis? Three tubes, two choices: Rapid Test or ELISA. Complete the form below, and our team will reach out with more information about [...]

Please note: The proof of chlamydia trachomatis serotypes L1- L3 is to be reported since September 2022 We would like to draw your attention to the crucial importance of differentiating between [...]

Dramatic rise in syphilis infections: Warning of underestimated risk In recent years, the healthcare world has seen a concerning surge in syphilis infections. Between 2020 and 2022, reported [...]

The EU has created a new legal framework for the quality and safety of in-vitro medical devices, namely the IVDR (Regulation on in-vitro diagnostic medical devices), which sets legally binding [...]

Mississauga, Canada and Darmstadt, Germany, 15th May  2020 – R-Biopharm AG  and Microbix Biosystems Inc. (TSX: MBX, Microbix®), a life sciences innovator, announces the appointment of R-Biopharm [...]